---
title: "Equifax, Inc. Stock 12‑Month Price Target Cut to $223.32, Implies 41% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286798681.md"
description: "Equifax, Inc.'s average stock price target has been reduced from $224.45 to $223.32, suggesting a potential upside of 41% based on the May 15 closing price. The consensus rating remains 'Buy' from 29 analysts, with 19 Buys and 10 Holds."
datetime: "2026-05-18T16:20:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286798681.md)
  - [en](https://longbridge.com/en/news/286798681.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286798681.md)
---

# Equifax, Inc. Stock 12‑Month Price Target Cut to $223.32, Implies 41% Upside

-   According to estimates from 22 analysts, Equifax, Inc. stock's average price target has fallen from $224.45 to $223.32, with forecasts ranging from $195 to $265 per share
-   Based on the May 15 closing price, the updated target implies approximately 41% potential upside
-   Consensus rating remains at “Buy” across 29 covering analysts, with 19 Buys, 10 Holds and 0 Sells

Explore more price target data and ratings for Equifax, Inc. on the , and track all previous and future analyst recommendations for Equifax, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [EFX.US](https://longbridge.com/en/quote/EFX.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Equifax, Inc. $EFX Shares Bought by Canada Post Corp Registered Pension Plan](https://longbridge.com/en/news/286666460.md)
- [Madison Asset Management LLC Sells 33,419 Shares of Equifax, Inc. $EFX](https://longbridge.com/en/news/286390165.md)
- [Best Buy leak hints GTA VI pre-orders may start May 18](https://longbridge.com/en/news/286472709.md)
- [The S&P 500 Just Completed Its 7th Straight Up Week. History Says It's Still Time to Buy.](https://longbridge.com/en/news/287006210.md)
- [Assessing BioMarin Pharmaceutical (BMRN) Valuation After Prolonged Share Price Weakness](https://longbridge.com/en/news/286895616.md)